Publication | Closed Access

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Lipid DisorderCardiovascular DiseaseMedicineDyslipidemic PatientsCardiovascular PharmacologyHyperlipidemiaPharmacotherapyPharmacologyDyslipidemia